Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

March 15, 2017

Certain Bacteria Within Gut Microbiome May Halt Inflammation Naturally, Study Says

News

Bacteria naturally present in our gut may be central for reversing inflammation detected in gut inflammatory diseases, such as inflammatory bowel disease (IBD). That finding was reported in the study “NLRP12 ... Read more

March 3, 2017March 3, 2017

Genetic Signatures Can Help Predict Likelihood of Complications in Young Crohn’s Patients

News

Specific biological markers in pediatric patients newly diagnosed with Crohn’s disease can help to predict those who will go on to develop disease-related complications, and those will best respond to treatment. The study, “Prediction ... Read more

February 28, 2017

Medicines Targeting Inflammatory Factor IL-1 May Help Combat IBD, Study Suggests

News

Scientists have discovered a potent inflammatory factor called interleukin (IL)-1 that is released during necroptosis, a type of cell death by suicide often present in inflammatory bowel disease (IBD). The ... Read more

February 22, 2017

Entyvio for IBD Shows Promising Safety Results in Long-term Clinical Trial

News

Takeda Pharmaceuticals recently presented positive five-year results of an eight-year clinical trial (NCT00790933) evaluating the long-term safety of Entyvio (vedolizumab) in patients with active ulcerative colitis and Crohn’s disease, two of the ... Read more

February 16, 2017

IBD Patients’ Gut Microbiome Suffers Huge Shifts Throughout Disease Course, Study Shows

News

The gut microbiome of people with inflammatory bowel disease (IBD) fluctuates more compared to those of healthy individuals. These findings suggest that therapies targeting some of these alterations within the ... Read more

February 10, 2017May 23, 2017

Researchers Identify Bacterial Link Between Crohn’s Disease and Joint Pain

News

An invasive type of Escherichia coli (E. coli) bacteria involved in gut inflammation in Crohn’s disease (CD) promotes joint pain, researchers have found. This information may help identify CD patients more ... Read more

February 1, 2017February 1, 2017

Protein Variant Protects Against IBD, Colon Cancer in Mice, Study Shows

News

A protein variant called IRAK-M is capable of protecting mice against inflammatory bowel disease (IBD) and certain forms of colon cancer, researchers have found. This outcome eventually could be a ... Read more

December 16, 2016

A Single Gene Variant, Once an Evolutionary Edge, Now Seen to Promote Diseases Like IBD

News

An alteration in a single gene, the Fads1 gene, may determine the risk for certain diseases, including inflammatory syndromes like inflammatory bowel disease (IBD). The study tracing the gene in human evolution ... Read more

November 11, 2016

Lung Function Tests May Indicate Another Problem for IBD Patients, Study Shows

News

Researchers recently determined that patients with inflammatory bowel diseases (IBDs) are likely to have pulmonary function problems that often go undiagnosed. The study, “Alterations of pulmonary function in patients with ... Read more

September 28, 2016

Protein Found Vital for Controlling Inflammation in Crohn’s Disease; Possible Therapeutic Target for IBD

News

Researchers have found that protein kinase C (PKC) λ/ι is an important player for maintaining intestinal epithelium balance and preventing intestinal inflammation. Patients with inflammatory bowel diseases (IBD) such as Crohn’s disease ... Read more